The Claim
A two-week intervention with 600 mg of inositol hexaphosphate (IP6) administered twice daily reduces fasting serum uric acid levels through inhibition of intestinal purine absorption, as renal excretion of uric acid remains unchanged and the observed effect is consistent with prior findings on postprandial uric acid suppression.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking 600 mg of inositol hexaphosphate twice daily for two weeks lowers fasting uric acid levels in the blood by reducing how much purine is absorbed from the intestines, without changing how much uric acid is removed by the kidneys.
See the scientific wording
The reduction in fasting serum uric acid observed after two weeks of 600 mg inositol hexaphosphate (IP6) twice daily is likely due to inhibition of intestinal purine absorption, as renal excretion remains unchanged and the effect aligns with prior findings on postprandial uric acid suppression.
Inositol hexaphosphate binds to purines in the intestine, preventing them from being absorbed into the bloodstream. With fewer purines reaching the liver, less uric acid is made, which lowers the amount in the blood. The kidneys continue to remove the same amount of uric acid, so the drop in blood levels comes only from reduced production.
What the research says
1 studyTaking IP6 supplements for two weeks lowered uric acid in the blood without changing how much uric acid the kidneys removed, which means it probably works by stopping the gut from absorbing too much uric acid from food.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.